QTTB
Q32 Bio Inc.
NASDAQ · Healthcare · Biotechnology · US
$7.79
+3.59%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 463.81x
Trailing multiples
Trailing twelve months
- P/E TTM
- 2.79x
- PEG TTM
- —
- Price / book
- 2.19x
- Price / sales
- 4.32x
- Price / cash flow
- -11.70x
Enterprise value
- Enterprise value
- $130.9M
- EV / sales
- 2.44x
- EV / EBITDA
- 3.79x
- EV / EBIT
- 6.10x
- Market cap
- $231.9M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026